Trial Profile
Phase II proof-of-concept Trial of clarithromycin/clofazimine/rifabutin in Type 1 Diabetes Mellitus Patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2014
Price :
$35
*
At a glance
- Drugs Clarithromycin/clofazimine/rifabutin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- Sponsors RedHill Biopharma
- 28 Jul 2014 New trial record